Industry Biotechnology (See Other Companies in Industry)
1600 Eastlake Ave East Suite 300| Date | Filing Type | Offered | Sold | Type | Link to Raw Filing |
|---|---|---|---|---|---|
| 2012-05-18 | New Form D | Offered: $300,000 | Sold: $0 | Type: Other | Raw Filing |
| 2012-02-03 | New Form D | Offered: $4,004,000 | Sold: $2,502,500 | Type: Debt Only | Raw Filing |
| 2007-11-09 | Paper Filing | Offered: N/A | Sold: Unknown | Type: Other | Raw Filing |
| 2007-05-07 | Paper Filing | Offered: N/A | Sold: Unknown | Type: Other | Raw Filing |
| 2005-11-22 | Paper Filing | Offered: N/A | Sold: Unknown | Type: Other | Raw Filing |
| 2005-09-13 | Paper Filing | Offered: N/A | Sold: Unknown | Type: Other | Not Available |
| Name | Role | Address |
|---|---|---|
| John Bencich | Executive | C/O Allozyne, Inc. 1600 Fairview Ave. E., Suite 300 Seattle, WA, 98102 |
| Meenu Chhabra | Director, Executive | C/O Allozyne, Inc. 1600 Fairview Ave. E., Suite 300 Seattle, WA, 98102 |
| Steven Gillis | Director | C/O Arch Venture Partners 1000 Second Ave., Suite 3700 Seattle, WA, 98104 |
| Kenneth Grabstein | Executive | C/O Allozyne, Inc. 1600 Fairview Ave. E., Suite 300 Seattle, WA, 98102 |
| Michael Steinmetz | Director | C/O Clarus Ventures 101 Main St., Suite 1210 Cambridge, MA, 02142 |
| David Tirrell | Director | C/O Allozyne, Inc. 1600 Fairview Ave. E., Suite 300 Seattle, WA, 98102 |
| Carl Weissman | Director | C/O Ovp Partners 1010 Market St. Kirkland, WA, 98033 |